Optimi Health (OPTH) Stock Price, News & Analysis

Company Overview

Optimi Health Corp. is a Canadian pharmaceutical company focused on developing and manufacturing psychedelic compounds for medical use. Its products include psilocybin produced from mushrooms and MDMA manufactured to pharmaceutical quality standards at its facilities in British Columbia.

The company’s psychedelic products are intended for clinical research and regulated medical use, including access programs where permitted. Optimi has also shipped products to Australia, where certain psychedelic-assisted treatments may be prescribed by authorized clinicians under national regulations.

In addition to its pharmaceutical business, Optimi has marketed functional mushroom supplements under the Optimi Life brand. Its work spans the development, production and distribution of psychedelic medicines and mushroom-based wellness products.

Key Stats

• Today's Range: $2.03 to $2.31
• 50-Day Range: $2.11 to $5.07
• 52-Week Range: $1.90 to $6.40
• Volume: 40,284 shs
• Average Volume: 37,947 shs
• Market Capitalization: $12.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Optimi Health Stock Analysis - MarketRank™

Optimi Health scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Reduce

Consensus Rating

Optimi Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

Optimi Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Optimi Health is -2.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Optimi Health is -2.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.38% of the float of Optimi Health has been sold short.

Short Interest Ratio / Days to Cover

Optimi Health has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Optimi Health has recently decreased by 15.30%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Optimi Health does not currently pay a dividend.

Dividend Growth

Optimi Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.91

News Sentiment

Optimi Health has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Optimi Health this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for OPTH on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Optimi Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Optimi Health insiders have not sold or bought any company stock.

Percentage Held by Institutions

Optimi Health has minimal institutional ownership at this time.

Company Calendar

• Today: 11/15/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:OPTH
• CIK: 2027329
• Web: www.optimi.net
• Phone: 778-761-4551
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 0.06
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: $310 thousand
• Price / Sales: 41.59
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,730,000
• Free Float: N/A
• Market Cap: $12.89 million
• Optionable: N/A
• Beta: N/A